secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001193125-26-003509
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Cyclerion Therapeutics enters collaboration with Medsteer for CYC-126 anesthetic delivery system
--------------------------------------------------------------------------------

- Cyclerion entered a Collaboration and Option Agreement with Medsteer for an anesthetic delivery system for treatment-resistant depression.
- Medsteer granted an exclusive option for a worldwide license of its technology, with upfront nominal payment and up to $3.7M in milestones.
- Cyclerion plans to initiate Phase 2 proof-of-concept study of CYC-126 in second half of 2026, targeting first patient in Australia.
- Medsteer's technology has been used in over 9,000 patients and 25 clinical settings.
- Collaboration includes joint development of closed-loop anesthetic delivery platform with real-time EEG monitoring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000119312526003509/0001193125-26-003509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000119312526003509/d23253d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-003509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer